The Ingestible Sensors Market size is valued at USD 992.3 Mn in 2026.
The Ingestible Sensors Market is projected to grow at a CAGR of 8% through 2033.
The Ingestible Sensors Market growth is driven by rising need for real-time patient monitoring, medication adherence, and increasing prevalence of chronic diseases.
North America is the dominating region for the Ingestible Sensors Market.
Proteus Digital Health, Medtronic plc, Abbott Laboratories, Otsuka Pharmaceutical Co., Ltd., and Boston Scientific Corporation are some leading industry players in the Ingestible Sensors Market.